Drug Trial Radar · NCT04271488
Study to Evaluate the Pharmacokinetics (PK) of E7090 (Herein Referred to as Tasurgratinib) and Its Metabolite in Participants With Mild and Moderate Hepatic Impairment Compared to Healthy Participants
Last checked: Nov 19, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
18
Planned (sponsor's estimate)
Start
Feb 27, 2020
Primary completion
Aug 31, 2027
Study completion Aug 31, 2027
Sponsor
- Lead sponsor
- Eisai Co., Ltd.Eisai
- Sponsor type
- Industry
- First posted
- Feb 17, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years, up to 79 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary purpose of the study is to evaluate the effects of mild and moderate hepatic impairment on PK of tasurgratinib after a single dose administration.
Conditions
- Hepatic Impairment
Interventions
TasurgratinibDrug
Tasurgratinib oral tablet.
TasurgratinibDrug
Tasurgratinib oral capsule.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cmax: Maximum Observed Plasma Concentration of TasurgratinibTime frame: Day 1: 0-144 hours postdose
- AUC(0-t): Area Under the Plasma Concentration versus Time Curve from Time 0 to Time of Last Quantifiable Concentration of TasurgratinibTime frame: Day 1: 0-144 hours postdose
- AUC(0-inf): Area Under the Plasma Concentration versus Time Curve from Time 0 to Infinity of TasurgratinibTime frame: Day 1: 0-144 hours postdose
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Eisai Trial Site #7
Kyoto, Japan · Recruiting
Eisai Trial Site #6
Hakata, Fukuoka, Japan · Recruiting
Eisai Trial Site #4
Kurume, Fukuoka, Japan · Terminated
Eisai Trial Site #2
Yuhu, Oita Prefecture, Japan · Recruiting
Eisai Trial Site #3
Bukyo-ku, Tokyo, Japan · Recruiting
Eisai Trial Site #1
Mintato-ku, Tokyo, Japan · Recruiting
Eisai Trial Site #8
Shinjuku-ku, Tokyo, Japan · Recruiting
Eisai Trial Site #5
Kofu, Yamanashi, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.